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Formamidopyrimidines (Fapy) lesions result from ring opening of the imidazole portion of purines. Fapy lesions can isomerize
from the natural β-anomeric stereochemistry to the α-conﬁguration. We have unambiguously demonstrated that the α-methyl-
Fapy-dG (MeFapy-dG) lesionis asubstratefor EscherichiacoliEndonuclease IV(EndoIV).Treatment of aMeFapy-dG-containing
24 mer duplex with Endo IV resulted in 36–40% incision. The catalytic eﬃciency of the incision was comparable to that of α-dG
in the same duplex sequence. The α-a n dβ-MeFapy-dG anomers equilibrate to ∼21:79 ratio over ∼3 days. Related studies with a
duplex containing the α-Fapy-dG lesion derived from aﬂatoxin B1 epoxide (α-AFB-Fapy-dG) showed only low levels of incision. It
is hypothesized that the steric bulk of the aﬂatoxin moiety interferes with the binding of the substrate to Endo IV and the incision
chemistry.
1.Introduction
Formamidopyrimidines (Fapy) are DNA lesions that result
from ring opening of the imidazole portion of purines.
Fapy lesions derived from dG can form by either initial
oxidation or N7-alkylation of the guanine base (Scheme 1)
[1–6]. These are structurally related lesions that diﬀer by the
substitution at the N5-formamide. The formyl nitrogen of
theFapy-dGderivedfromoxidativedamageisunsubstituted,
and it has been proposed that recognition of this lesion
by human OGG involves hydrogen-bonding interactions
between the protein and this functional group [7]. The
formyl nitrogen is substituted with the alkylating agent from
the alkylative pathway, and this substitution is likely to
change the conformation of the adduct and its interaction
with repair proteins and DNA polymerases. The corre-
sponding Fapy-dG adducts were shown to be the persistent
DNA lesions resulting from exposure to methylating agents
(MeFapy-dG) and aﬂatoxin B1 (AFB-Fapy-dG) [8–10].
An unusual property of Fapy lesions is that the C1
 
stereochemistry can interconvert between the β-a n dα-
anomers.ThispresumablyoccursthroughtheN 6-C1
  imine
intermediate [11, 12]; the pyranose form can also result at
the nucleoside level [13, 14]. The α-anomer of dA, dT, and
dC results from γ-radiolysis of DNA [15, 16]; however, the
α-stereochemistry of these lesions is static once it is formed.
Escherichia coli Endonuclease IV (Endo IV) is a double-
strand speciﬁc AP endonuclease that hydrolyzes the phos-
phodiester bond on the 5 -side of abasic sites and accounts
for ∼10% of the AP endonuclease activity in E. coli [17–19].
The incision of the damaged strand results in a 5 -terminal
ribosyl-5 -phosphateonthedownstreamfragmentandafree
3 -hydroxyl group of the upstream fragment. Endo IV also
possesses 3 -diesterase activity and can remove 3 -blocking
groups such as 3 -phosphates, 3 -phosphoglycolate, and the
3 -(4-hydroxy-2-pentenal)-5-phosphate group that results
from β-elimination of abasic sites. Endo IV was also found
to possess 3  → 5  exonuclease activity and can generate a
single base gap at the 5 -side of a damaged base [20, 21].
Endo IV contains three Zn2+ atoms in its active site and
recognizes the damage site by a double nucleotide-ﬂipping
mechanism [22–24]. Oligonucleotides containing the α-
dA, α-dT, α-dC, α-Fapy-dA, and α-Fapy-dG lesions as well
as the conﬁgurationally stable N6-carbon Fapy analogues2 Journal of Nucleic Acids
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Scheme 1: Fapy-dG lesions derived from oxidative or alkylative
damage to dG.
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Scheme 2: The β-a n dα-anomers of Fapy-dG.
α-C-Fapy-dA have been shown to be substrates for Endo IV
[25–29]. Oligonucleotides containing MeFapy-dG have also
been examined as potential substrates for Endo IV. Asagoshi
et al. reported that a MeFapy-dG-containing oligonucleotide
was not a substrate for Endo IV and concluded that
this lesion existed as the β-MeFapy-dG anomer [30, 31].
However,Ishchenko et al. [32] reported incision of the
MeFapy-dG lesion with a catalytic eﬃciency comparable to
that reported for α-C-Fapy-dA [29]. Interestingly, evidence
that Endo IV plays a role in the repair of deoxyribosylurea
lesions has also been reported [33]; this lesion can also
undergo anomerization, and it is likely that the α-anomer is
as u b s t r a t ef o rE n d oI V[ 34–36].
Werecentlydescribedthesynthesisofaphosphoramidite
reagent of the MeFapy-dG lesion and its utility in the site-
speciﬁc synthesis of modiﬁed oligonucleotides [11]. Two
transitions were observed in the thermal melting curve of
a 12-mer duplex containing a MeFapy-dG lesion. The lower
melting transition was assigned as the α-MeFapy-dG anomer
and the higher melting transition as the β-anomer. These
assignments were based on a similar thermal melting proﬁle
of the AFB-Fapy-dG adduct for which the conformations of
the α-a n dβ-anomers (Scheme 2) have been determined by
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Figure1:StructuresofthemethylandaﬂatoxinB1 Fapy-dGlesions.
NMR [37, 38]. The α : β anomeric ratio of the MeFapy-
dG adduct was estimated to be ∼40:60. We report here the
selective incision of the α-MeFapy-dG anomer from duplex
DNA by Endo IV.
2.MaterialsandMethods
α-dG was purchased from Berry and Associates, Inc. and
was converted to its phosphoramidite reagent using standard
protocols [39]. T4 polynucleotide kinase and E. coli Endo
IV were purchased from New England Biolabs. γ-32P-ATP
was purchased from PerkinElmer Life Sciences. Unmodiﬁed
oligonucleotides were purchased from Midland Certiﬁed
Reagents. MALDI-TOF mass spectra were recorded using
a 3-hydroxypicolinic acid (HPA) and ammonium hydrogen
citrate matrix.
Oligonucleotide Synthesis. The MeFapy-dG and AFB-Fapy-
dG modiﬁed oligonucleotides were synthesized as previously
described[11,40].Theα-dG-containingoligonucleotidewas
synthesized via the phosphoramidite method. The purity
of all oligonucleotides was judged to be >99% by capillary
gel electrophoresis. Oligonucleotides were characterized by
MALDI-TOF mass spectrometry and enzymatic digestion.
5 -ACCACGCTAGC-(α/β-MeFapy-dG)-AGTCCTAACAAC-
3 . It was puriﬁed by reversed-phase HPLC using gradient 1
and further puriﬁed by PAGE. MALDI-TOF MS (HPA) m/z
calcd for (M-H), 7304.4; found 7305.4.
5 -ACCACGCTAGC-(α-dG)-AGTCCTAACAAC-3 . It was
puriﬁed by reversed-phase HPLC using gradient 2. MALDI-
TOF MS (HPA) m/z calcd for (M-H), 7272.2; found
7272.3.
5 -ACCACTACTAT-(α-AFB-Fapy-dG)-ATTCATAACAAC-3 .
It was puriﬁed by reverse-phase HPLC using gradient 3.Journal of Nucleic Acids 3
MALDI-TOF MS (HPA) m/z calcd for (M-H), 7593.2; found
7594.1.
HPLC Puriﬁcation. A YMC ODS-AQ column (250 ×
4.6mm, ﬂow rate 1.5mL/min; 250 × 10mm, ﬂow rate
5mL/min) or Phenomenex Gemini-C18 column (250 ×
4.6mm, ﬂow rate 1.5mL/min; 250 × 10mm, ﬂow rate
5mL/min) was used for oligonucleotide puriﬁcations and to
monitor reactions. Oligonucleotides were detected by their
UV absorbance at 254nm. The mobile phase consisted of
CH3CN and 100mM ammonium formate buﬀer (v/v).
Gradient 1. Initial conditions were 1% CH3CN; a linear gra-
dient to 8% CH3CN over 5minute; a linear gradient to 13%
CH3CN over 15minute; a linear gradient to 80% CH3CN
over 2minute; isocratic at 80% CH3CN for 2minute; then
a linear gradient to the initial conditions over 3minute.
Gradient 2. Initial conditions were 1% CH3CN; a linear gra-
dient to 5% CH3CN over 5minute; a linear gradient to 10%
CH3CN over 15minute; a linear gradient to 80% CH3CN
over 2minute; isocratic at 80% CH3CN for 2minute; then
a linear gradient to the initial conditions over 3minute.
Gradient 3. Initial conditions were 6% CH3CN; a linear
gradient to 25% CH3CN over 25minute; a linear gradient
to 80% CH3CN over 2minute; isocratic at 80% CH3CN for
2minute; then a linear gradient back to the initial conditions
over 3minute.
LC-ESI-MS Analysis. MS analysis was performed in the
Vanderbilt University facility on a Waters Acquity UPLC
system connected to a Finnigan LTQ mass spectrometer
(ThermoElectron) equipped with an Ion Max API source
and a standard electrospray probe using an Acquity UPLC
BEH C18 column (1μm, 1.0mm × 100mm). LC conditions
were as follows: buﬀer A contained 10mM NH4CH3CO2
plus 2% CH3CN (v/v), and buﬀer B contained 10mM
NH4CH3CO2 plus 95% CH3CN (v/v). The following gra-
dient program was used with a ﬂow rate of 150μL/min:
initially 0% B, 3minute linear gradient to 3% B,1 . 5m i n u t e
linear gradient to 20% B, 0.5minute linear gradient to
100% B, isocratic at 100% B for 0.5minute, 1minute linear
gradient to 0% B, and isocratic at 0% B for 3minute. The
temperature of the column was maintained at 50
◦C, and
the samples (10μL) were infused with an autosampler. The
electrospray conditions were as follows: source voltage: 4kV;
source current: 100μA; N2 was used as the auxiliary gas
at a ﬂow rate setting of 20; sweep gas ﬂow-rate setting,
5: sheath gas ﬂow setting: 34; capillary voltage: −49V;
capillary temperature, 350
◦C; and tube lens voltage: −90V.
The automatic gain control (AGC) setting in full MS was
10000. The maximum injection time in full MS was 10ms.
T h eM Sd a t aw e r ea c q u i r e di nn e g a t i v em o d e .T h en u m b e r
of μscan used for data acquisition in full MS was 2. Product
ion spectra were acquired over the range of m/z 345–2000.
Oligonucleotide Labeling and Annealing. The labeling of the
MeFapy-dG oligonucleotide was performed as previously
described using T4 polynucleotide kinase and γ-32P-ATP
[41]. Electrophoresis gels were exposed to a PhosphorImager
screen (Imaging Screen K, Bio-Rad) overnight. The bands
were visualized with a PhosphorImaging system (Bio-Rad,
Molecular Imager FX) using the manufacturer’s Quan-
tity One software, version 4.3.0. Unless otherwise noted,
the oligonucleotide duplexes were formed by annealing
the 5 -32P-labeled MeFapy-dG-containing oligonucleotide
(200nM) with its complementary strand (600nM) in Tris
buﬀer (100μL ,5 0 m M ,p H8 . 0 )a t9 5
◦C for 5minute; the
solution was then slowly cooled to ambient temperature over
1h.
Time Course Incision of the MeFapy-dG and α-dG-Containing
Duplexes by Endo IV. The oligonucleotide duplex (4μL,
0.8pmols) was added to the Endo IV reaction buﬀer (74μL
of 1X:100mM NaCl, 50mM Tris-HCL, 10mM MgCl2,a n d
1mM dithiothreitol, pH 7.9) and warmed to 37
◦C. Endo IV
(0.08nM) was added; aliquots (5μL) were removed at the
appropriatetimes,addedto10μLof95%formamideloading
buﬀer containing xylene cyanol and bromophenol blue dyes,
a n dh e a t e df o r1m i n u t ea t9 0
◦C. Aliquots (6μL) from the
samples were separated by electrophoresis on a denaturing
gel.
To determine the extent of background deglycosylation
ofthelesion,aliquotsoftheMeFapy-dG-containingoligonu-
cleotide were treated with 0.1M NaOH and incubated
at 37
◦C for 20minute. The samples were neutralized by
addition of 0.1M HCl, diluted with loading buﬀer, and
analyzed by gel electrophoresis. The amount of the cleavage
in this control experiment was subtracted from the amount
of incision in the Endo IV reactions. Reactions were carried
out in duplicate. The same procedure was used for the
incision of the 5 -32P-labeled α-dG-containing duplex.
Incision of the α-AFB-Fapy-dG-Containing Duplex by Endo
IV. The 5 -32P-labeled α-AFB-Fapy-dG oligonucleotide
(120nM) was annealed to its complementary strand
(160nM) in Tris buﬀer (100μL, 50mM, pH 8.0) at room
temperature. Aliquots (10μL, 120nM) were taken every
5minute and added to a mixture of Endo IV enzyme buﬀer
(10X, 6μL), water (40μL), and Endo IV (0.4nM) at 37
◦C;
the incision reactions were incubated at 37
◦C and pH 7.9.
Aliquots (5μL) were taken every 2minute and added to
10μL of 95% formamide loading buﬀer containing xylene
cyanol and bromophenol blue dyes and heated for 1minute
at90
◦C. Aliquots(6μL)wereseparated byelectrophoresison
a denaturing gel. The extent of background deglycosylation
of the α-AFB-Fapy-dG lesion was determined as described
above. The amount of the cleavage in the control experiment
was subtracted from the amount of incision in the Endo IV
reactions. Reactions were carried out in duplicate.
Kinetics for the Incision of the MeFapy-dG- and α-dG-
Containing Duplexes by Endo IV. The duplex was annealed4 Journal of Nucleic Acids
as described above with the following modiﬁcations. The 5 -
32P-labeled MeFapy-dG and its complementary strand were
100 and 150nM, respectively. Endo IV (0.08nM) was added
to varying concentrations of the DNA duplex (0.5–35nM in
1X Endo IV reaction buﬀer, pH 7.9) to a ﬁnal volume 50μL.
R e a c t i o n sw e r er u na t3 7
◦C for up to 10minute. Aliquots
(5μL) were taken at 1minute intervals, added to loading
buﬀer (10μL), and heated at 90
◦C for 1minute. Separation
was achieved by gel electrophoresis. The kinetics parameters
were calculated using KaleidaGraph 4.0. Reactions were
carried out in duplicate. The same procedure was used for
incision of the α-dG-containing duplex.
Time Course Incision of the MeFapy-dG-Containing Duplex
by Endo IV at pH 7.0. The oligonucleotide duplex (12μL,
2.4pmols) was added to the Endo IV reaction buﬀer
(100mM NaCl, 50mM Tris-HCl, 10mM MgCl2,1 m M
dithiothreitol, pH 7, 222μL), followed by addition of Endo
IV (0.08nM). The reaction was incubated at 37
◦Cf o r5
days. A fresh portion of Endo IV (0.08nM) was added every
24h. Aliquots (5μL) were removed 30minute after the Endo
IV addition, added to 10μL of 95% formamide loading
buﬀer containing xylene cyanol and bromophenol blue dyes,
a n dh e a t e df o r1m i n u t ea t9 0
◦C. The incision reaction was
analyzed by gel electrophoresis. The experiment was run in
duplicate.
Incision of the MeFapy-dG-Containing Duplex after Denat-
uration and Reannealing. The DNA duplex was formed
as described above with the following modiﬁcations. The
5 -32P-labeled MeFapy-dG and its complementary strand
were 200 and 400nM, respectively. The oligonucleotide
duplex (8μL, 1.6pmols) was added to 1X Endo IV reaction
buﬀer (148μL), followed by addition of Endo IV (0.08nM).
T h er e a c t i o nw a sr u na t3 7
◦C for 40minute and aliquots
(5μL) were removed periodically, added to 10μL of 95%
formamide loading buﬀer containing xylene cyanol and
br omophenolblued y esandheat edfor1min ut eat90
◦C.The
remaining reaction mixture was heated at 95
◦Cf o r5m i n u t e ,
cooled to 75
◦C for 30minute, then cooled to ambient
temperatureover1h.ThereannealedDNAduplexincubated
at 37
◦C and Endo IV (0.08nM) was added. Aliquots were
taken as previously described, and the level of incision
was analyzed by gel electrophoresis. The denaturation and
reannealing cycles were repeated one more time.
LC-ESI-MS Analysis of the Incision of the MeFapy-dG-
Containing Duplex by Endo IV. MeFapy-dG-containing
24mer oligonucleotide (0.774nmol) was annealed to its
complimentary strand (1.5eq., 1.161nmol) in Tris buﬀer
(100μL, 50mM, pH 8.0) as described above. To this solution
Endo IV reaction buﬀer (13μL, 10X) was added followed
by addition of Endo IV (0.8nM). The reaction mixture was
incubated at 37
◦C for 2h. The reaction mixture was then
passed through a spin column (Bio-spin 6 Tris columns) and
lyophilized. The white residue was dissolved in water and
analyzed by LC-ESI-MS.
Incision of the MeFapy-dG-Containing Duplex by Endo IV at
pH 7.0. The DNA duplex was annealed as described above
in Tris buﬀer (50mM, pH 7.0). The oligonucleotide duplex
(12μL, 2.4pmols) was added to the Endo IV reaction buﬀer
(222μL,100mMNaCl,50mMTris-HCl,10mMMgCl2,and
1mM dithiothreitol, pH 7.0). The reaction was incubated
at 37
◦C. Aliquots (50μL) were removed after 1, 3, 5, 7,
and 10 days and treated with Endo IV (0.08nM). Aliquots
(8μL) were added to 10μL of 95% formamide loading buﬀer
containing xylene cyanol and bromophenol blue dyes and
heated for 1minute at 90
◦C. The experiment was run in
duplicate.
Thermal Melting (Tm) Analysis of the MeFapy-dG-Containing
12mer Duplex. A 1:1 mixture of MeFapy-dG contain-
ing 12mer oligonucleotide and its complementary strand
(0.25A260 units) were placed in melting buﬀer (0.5mL,
10mM Na2HPO4/NaH2PO4, 1.0M NaCl, and 50μM
Na2EDTA, pH 7.2). The UV absorbance of the duplex was
monitored 260nm as a function of temperature. Absorbance
measurements were taken at 1minute intervals with a
1◦C/min temperature gradient. The temperature was cycled
between 15 and 85
◦C. The ﬁrst derivative of the melting
curve was used to establish Tm values. After running the ﬁrst
Tm, the sample was incubated at 37
◦C for 5 days, then Tm
experiment was repeated.
3. Results and Discussion
3.1. Incision of MeFapy-dG-Containing Duplex by Endo IV.
The MeFapy-dG lesion was site speciﬁcally incorporated at
position 12 of the 24mer oligonucleotide shown in Figure 2
(X=MeFapy-dG)andannealedtoitscomplementarystrand.
The activity of Endo IV toward the MeFapy-dG lesion
when paired with dC was examined. PAGE analysis of the
reaction mixture typically showed between 36% and 40%
of the 5 -32P-ACCACGCTAGC-3  incision product after
30minute (Figure 2(a)). Increasing the initial concentration
of Endo IV or addition of a second portion of enzyme
after the initial 30minute incubation period did not increase
the amount of incised product. The incision reaction
was also followed by LC-ESI-MS with nonradiolabeled
oligonucleotides (Figure 3). In addition to the MeFapy-
dG-containing oligonucleotide (m/z = 1825.4 [M-4H] and
1460.3[M-5H])anditscomplementarystrand(m/z =1484.9
[M-5H] and 1237.2 [M-6H]), the 5 -ACCACGCTAGC-3 
(m/z = 1094.1 [M-3H] and 820.3 [M-4H]) and 5 -
p(MeFapy-dG)-AGTCCTAACAAC-3  (m/z = 1345.2 [M-
3H] and 1009.0 [M-4H]) incision products were observed.
After the initial incision of the MeFapy-dG-containing
duplex, the remaining 24mer duplex, which was presumably
highly enriched in the β-MeFapy-dG anomer, was dena-
tured by heating to 90
◦C, then slowly cooled to reanneal
the duplex. The heating and annealing cycle is expected
to equilibrate the α-a n dβ-anomers of the MeFapy-
dG lesion [29]. Additional Endo IV was added and the
5 -32P-ACCACGCTAGC-3  incision product was found to
be ∼59% (Figure 2(b)); the 23% increase of the incisionJournal of Nucleic Acids 5
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Figure 2: Gel electrophoretic analysis of the incision of the
MeFapy-dG containing duplex with E. coli Endo IV. (a) Incision
after the annealing of the 5 -32P-labelled MeFapy-dG containing
oligonucleotide (24mer) with its complement. The right lane is a
standard of the 5 -32P-ACCACGCTAGC-3  incision product. (b)
Percentage of the incision product after subsequent denaturation-
reannealing and additional Endo IV.
products represents ∼36% cleavage of the MeFapy-dG
duplex remaining (64%) after the initial Endo IV incision.
A subsequent denaturation-reannealing cycle followed by
addition of a third aliquot of Endo IV resulted in an
additional 14% increase of the incision product (73% total),
representing ∼34% cleavage of the MeFapy-dG-containing
duplex remaining after the prior two rounds of Endo IV
treatment (41%). These results are similar to those reported
by Patro et al. for the incision of the Fapy-dA containing
duplex and is consistent with selective incision of the α-
MeFapy-dG anomer [29].
The MeFapy-dG-containing oligonucleotide was also
hybridized to complementary strands in which the lesion
was mismatched with dG, dA, and dT. Treatment of these
duplexes with Endo IV and PAGE analysis resulted in 30%,
32%, and 30% incision, respectively. The reactions products
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Figure 3: Full-can mass spectrum of the Endo IV incision
of the MeFapy-dG containing duplex; m/z 1825.4 [M-4H]
and 1460.3 [M-5H] are the 5 -ACCACGCTAGC-(MeFapy-dG)-
AGTCCTAACAAC-3 , m/z 1484.9 [M-5H] and 1237.2 [M-6H] are
the 5 -GTTGTTAGGACTCGCTAGCGTGGT-3 , m/z 1094.1 [M-
3H] and 820.3 [M-4H] are the 5 -ACCACGCTAGC-3 ,a n dm/z
1345.2 [M-3H] and 1009.0 [M-4H]) is the 5 -p(MeFapy-dG)-
AGTCCTAACAAC-3  oligonucleotide.
from the mismatched duplexes were also characterized by
LC-ESI-MS analyses.
3.2. Steady-State Analysis for the Endo IV Incision of the
MeFapy-dG-Containing Duplex. Figure 4 shows the steady-
state kinetic analysis for the incision of MeFapy-dG strand
when paired with dC. The modiﬁed strand was incised with
a kcat = 5.5 ± 0.5min −1 and Km = 17.8 ± 3.8nM(kcat/Km =
0.33 ± 0.12nM−1 min−1; ﬁlled circles). When the DNA
concentration used in the rate calculation was adjusted to
reﬂect only the amount of the α-MeFapy-dG adduct (∼40%,
open circles), the catalytic eﬃciency improved to 0.78 ±
0.33nM−1 min−1 by virtue of a lower Km (7.1±1.5nM).This
treatment of the rate data assumes that the β-MeFapy-dG-
containing duplex does not inhibit Endo IV and is based on
the observation that the incision of duplex DNA containing
α-dA was not inhibited by the addition of an unmodiﬁed
duplex, even at concentrations 30-fold higher than the
substrate DNA [25]. For comparison, the phosphoramidite
reagent of α-dG was prepared and incorporated into the
same 24mer sequence; α-dG was chosen for this comparison
because of the commercial availability of the nucleoside. The
catalytic eﬃciency for the incision of the α-dG-containing
duplex (kcat/Km)w a s0 .69 ± 0.5nM −1 min−1 (kcat = 4.9 ±
0.5min −1 and Km = 7.1 ±1.0nM)(Figure 4 (b)).
3.3. Equilibration of the MeFapy-dG Anomers in DNA. The
α-MeFapy-dG lesion was excised from the 24mer duplex,
and the equilibration of the remaining β-MeFapy-dG to6 Journal of Nucleic Acids
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Figure 4: Steady-state kinetic analysis for the incision of the
MeFapy-dG-(a) and α-dG-(b) containing duplexes when the modi-
ﬁedbasewasoppositedC.TheEndoIVconcentrationwas0.08nM.
am i x t u r eo fα-a n dβ-anomers was monitored at 37
◦C
(Figure 5). Aliquots were taken every 24h after the initial
incision reaction and additional Endo IV was added; the
increase in the 5 -32P-ACCACGCTAGC-3  was attributed
to the anomerization of the β-MeFapy-dG remaining after
initial incision. The prolonged exposure of the incision
product to Endo IV resulted in its conversion to a product
one nucleotide shorter. We attribute this observation to the
3  → 5  exonuclease activity of Endo IV, and the product
is presumably 5 -32P-ACCACGCTAG-3  [20]. Virtually no
anomerization was observed at pH 8.0, consistent with
studies that showed that the anomerization of the AFB-
Fapy-dG lesion was acid catalyzed [40]. We found that the
anomeric stereochemistry of the β-MeFapy-dG equilibrated
over ∼5d a y st oa nα : β ratioof ∼21:79 atpH 7.0 and 37
◦C.
To insure that the additional cleavage of the duplex was not
due to fortuitous deglycosylation of the MeFapy-G base, the
MeFapy-dG-containing duplex was incubated at 37
◦Cf o r5
days, then E. coli Endonuclease V was added, which is known
to cleave abasic sites. No cleavage was observed.
-ACCACGCTAGCXAGTCCTAACAAC-
-TGGTGCGATCGCTCAGGATTGTTG-
32P -
39 39 44 52
Incision (%)
0.5 24 72 120
Time (hr)
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3 
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(a)
-ACCACGCTAGCXAGTCCTAACAAC-
-TGGTGCGATCGCTCAGGATTGTTG-
32P -
40 30 23 23
Incision (%)
0.5 24 72 120
Time (hr)
5 
3 
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5 
(b)
Figure 5: Gel electrophoretic analysis of the equilibration of the
β-a n dα-MeFapy-dG anomers in duplex DNA. (a) Anomerization
of the β-MeFapy-dG after initial incision with Endo IV. Aliquots
were treated with additional Endo IV every 24h; the increase in
the incision product is attributed to equilibration of the β-MeFapy-
dG to the α-anomer. (b) Treatment of the MeFapy-dG-containing
duplex with Endo IV after incubation at 37◦C, pH 7.0 for up to 5
days.
The duplex that resulted from annealing the MeFapy-dG
modiﬁed oligonucleotide with its complement initially con-
tained ∼36%–40% of the α-MeFapy-dG. The equilibration
oftheα-MeFapy-dGanomertotheβ-anomerwasmonitored
by incubating the annealed duplex at 37
◦C and treating
aliquots with Endo IV (Figure 5 (b)). We observed that the
α : β anomeric ratio was ∼30:70 after 24h and 23:77 after
3 days; the reaction was monitored up to 10 days, and the
percentage of incision product remained at ∼23%. These
results are in good agreement with those starting from the
β-anomer.Journal of Nucleic Acids 7
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Figure 6:Thermalmeltinganalysisofthe12merduplexcontaining
the MeFapy-dG lesion opposite dC after 5 days at 37◦C. The Tm for
the unmodied duplex was 59◦C.
We initially reported that the thermal melting (Tm)
curve of a 12mer duplex containing the MeFapy-dG lesion
did not change over time [11]; these studies were con-
ducted at 5◦C. The thermal melting temperature of the
12mer duplex 5 -GCTAGC-(MeFapy-dG)-AGTCC-3  · 5 -
GGACTCGCTAGC-3  was reexamined by monitoring the
hyperchromicity of the DNA UV absorption at 260nm as
af u n c t i o no ft e m p e r a t u r e( Figure 6). This duplex has the
same local sequence as the 24mer duplex used for the
Endo IV incision studies. The duplex was incubated at 37
◦C
for 5 days then analyzed. The Tm values were determined
by taking the ﬁrst derivative of the melting and annealing
curves. As previously reported, two transitions were present
in the melting cycle; however, the relative proportions of
the transitions diﬀered after 5 days at 37
◦C. The higher
melting transition (Tm =50
◦C), which was assigned as the
β-MeFapy-dG anomer, made up ∼80% of the duplex after
the incubation period. The Tm curve for the annealing
cycle was displaced from the heating cycle, reﬂecting that
the reannealing of the MeFapy-dG oligonucleotide with its
complement resulted in a diﬀerent α : β anomeric ratio than
after equilibration for 5 days. Similar melting and annealing
proﬁles were recently reported for a duplex containing the
AFB-Fapy-dG lesion [38]. These studies are consistent with
the Endo IV incision data.
The initial anomeric ratio (∼36:64) after annealing
the MeFapy-dG-containing oligonucleotide with its comple-
ment may reﬂect the ratio in single-strand DNA. The α-
and β-MeFapy-dG anomers equilibrate over several days and
reach a ﬁnal α : β ratio of ∼21:79. The equilibration studies
may provide insight to the conﬂicting reports by Asagoshi
et al. regarding the Endo IV incision of the MeFapy-dG
lesion in DNA. The MeFapy-dG-containing duplexes were
prepared diﬀerently. Ishchenko et al. prepared the MeFapy-
dG lesion by treating a single-stranded oligonucleotide
containing a single dG with a methylating agent [32]; the
resulting 7-methyl-dG was then subjected to base treatment
togeneratetheMeFapy-dGlesion.AnnealingoftheMeFapy-
dG-containing oligonucleotide is expected to contain both
the α-a n dβ-anomers as demonstrated in our studies.
Asagoshi et al. prepared a DNA duplex by incorporating 7-
methyl-dGTP opposite a template strand containing a single
dC with a DNA polymerase [30, 31]; alkali treatment of the
duplex produced the MeFapy-dG lesion. It is likely that ring
opening of β-7-methyl-dG in duplex DNA produced largely
or exclusively the β-MeFapy-dG anomer. We demonstrated
that the anomerization of the β-MeFapy-dG anomer is slow
at pH 7.0 and is expected to be slower at pH 7.5, the
conditions reported by Asagoshi et al. for the attempted
Endo IV incision [30]. It is possible that the β-MeFapy-dG
anomerhadnotequilibratedwhentreatedwithEndoIV,and
consequently, no incision was observed.
The MeFapy-dG lesion was shown to be the persistent
DNA lesion in rats treated with methylnitrosourea, 1,2-
dimethylhydrazine, and N,N-dimethylnitrosamine [8, 9].
The MeFapy-dG lesion was reported to be present 21 days
after exposure; these studies detected the MeFapy-G base,
thus information regarding the anomeric stereochemistry
was lost. As noted above, the MeFapy-dG lesion is likely to
be initially formed as the β-anomer; our observation that β-
MeFapy-dG will slowly equilibrate to ∼21% of the α-anomer
over 3–5 days suggests that the α-anomer is present in cells
due to the long-lived nature of this lesion and therefore may
be biologically relevant.
3.4. Incision of AFB-Fapy-dG by Endo IV. The 24mer
oligonucleotide containing the AFB-Fapy-dG lesion, 5 -
ACCACTACTAT-(AFB-Fapy-dG)-ATTCATAACAAC-3 ,w a s
synthesized as previously described, and the α-a n dβ-
AFB-Fapy-dG-containing oligonucleotides were separated
by HPLC [38]. The oligonucleotide containing the α-AFB-
Fapy-dG lesion was 5 -32P-end labeled and hybridized to its
complementary strand in which the lesion was opposite dC.
Treatment of this duplex (20nM) with Endo IV (0.08nM)
under the same conditions used for incision of the MeFapy-
dG-containing duplex resulted in ∼5% incision of α-AFB-
Fapy-dGmodiﬁedstrandafter30minute(Figure 7);thelevel
of incision did not increase after 90minute. The level of
incision reached ∼ 9% when the Endo IV concentration was
increased by 10-fold.
The activity of Endo IV toward the AFB-Fapy-dG lesion
was low in comparison to the MeFapy-dG lesion. The α-
AFB-Fapy-dG was reported to have completely isomerized
to the β-anomer over several days at pH 7.0 and 5◦C[ 37].
It is possible that the low level of incision observed for the
AFB-Fapy-dG-containing 24mer duplex was due to rapid
isomerization of the α-anomer to the β;h o w e v e r ,H P L C
analysis indicated that the level on the β-AFB-Fapy-dG
anomer was less than 5% over the 90minute reaction time
and conditions used to 32P-labeled the substrate. In Figure 1
a recent NMR structure of the α-AFB-Fapy-dG leson in a
5 -CTAT-(AFB-Fapy-dG)- ATTCA-3  ·5 -TGAATCATAG-3 
10mer duplex revealed that the AFB moiety was intercalated
to the 5 -side of the modiﬁed α-Fapy-dG base [38]a n dw e l l
stacked (Figure 8). The modiﬁed α-AFB-Fapy-dG base was8 Journal of Nucleic Acids
-ACCACTACTATXATTCATAACAAC-
-TGGTGATGATACTAAGTATTGTTG-
32P -
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Figure 7: Gel electrophoretic analysis of the incision of the α-AFB-
Fapy-dG-containing 5 -32P-labeled 24mer duplex by Endo IV. The
right lane is a standard of the 5 -32P-ACCACTACTAT-3  incision
product.
A:T
Fapy-G:C
AFB
T:A
Figure 8: Conformation of the α-AFB-Fapy-dG-containing 10mer
duplex.TheAFBmoiety(magenta)wasintercalatedtothe5 -sideof
the Fapy-G base, which was paired with its complement (pdb code
2KH3).
paired with its complementary dC, and both bases were
intrahelical. The 10mer sequence possesses the same local
sequence as the AFB-Fapy-dG containing 24mer used in this
study. The insertion of the Tyr-72 side chain of Endo IV into
the DNA helix plays an important role in the recognition
and catalytic mechanism by promoting the ﬂipping of the
abasic nucleotide along with its partner nucleotide into the
active site of the enzyme, stabilizing a 90
◦ bend in the DNA
and positioning the phosphate for hydrolysis. The position
of the bulky AFB group may severely interfere with the
binding of the substrate DNA to Endo IV and the incision
reaction [22, 23]. Alternatively, a solvent accessible pocket in
the active site of Endo IV is hypothesized to accommodate
α-nucleotides, and it is plausible that bulky lesions such
as the α-AFB-Fapy-dG cannot be readily accommodated in
this pocket [22]. Chromatographic evidence for a minor
conformation of the α-AFB-Fapy-dG in single strand was
reported [38]; the nature of this conformation is not clear
but the possibilities include geometric isomers of the amide
or atropisomers [14, 40, 42]. It is possible that Endo IV is
selectively incising this minor α-AFB-Fapy-dG conformer.
4. Conclusion
We unambiguously observed that the α-MeFapy-dG lesion
is a substrate for Endo IV. This activity was exploited to
probe the anomeric conﬁguration of the MeFapy-dG lesion
in duplexDNA. Endo IVwasusedtofollowthe equilibration
of the α-a n dβ-MeFapy-dG lesions, and we estimate the α :
β-ratio to be ∼21:79. Although the equilibration was slow,
it was faster than the repair of the MeFapy-dG lesion from
the DNA of rats. We conclude that the α-MeFapy-dG will be
present in mammalian cells, and its repair and replication
are therefore of interest. Only low levels of incision were
observed for the α-AFB-Fapy-dG-containing duplex. It is
likely that the bulkof the AFB moiety, whichwas intercalated
on the 5 -side of the modiﬁed base, interferes with substrate
recognition and the incision reaction by Endo IV.
The MeFapy-dG lesion has been shown to be a substrate
for the Fpg/Nei family of glycosylases [3, 30, 43–45]. It is
possible that Endo IV and the Fpg/Nei glycosylases have
distinct roles during the repair of the MeFapy-dG with Endo
IV incising the α-anomer and Fpg/Nei glycosylases excising
the β-anomer. The speciﬁcity of Endo IV for the α-MeFapy-
dG anomer may provide a valuable tool for uncovering the
mechanistic details of the repair of MeFapy-dG and related
lesions.
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